TherapeuticsMD
TXMD
$1.17
Share price
-1.68%
Change (1 day)
-32.37%
Change (1 year)
Categories
TherapeuticsMD (TXMD) - Net assets
Net assets on the balance sheet as of March 2025 : $26.74 Million USD
According to TherapeuticsMD's latest financial reports the company has $26.74 Million USD in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
TherapeuticsMD - Net assets on balance sheet (from 2001 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $$35.14 M | -137.54% |
| 2021-12-31 | $-$93.63 Million | -24.5% |
| 2020-12-31 | $-$0.13 Billion | -1447.67% |
| 2019-12-31 | $$9.2 M | -90.57% |
| 2018-12-31 | $$97.52 M | -24.93% |
| 2017-12-31 | $$0.12 B | 1.9% |
| 2016-12-31 | $$0.12 B | 102.16% |
| 2015-12-31 | $$63.06 M | 30.33% |
| 2014-12-31 | $$48.38 M | -11.53% |
| 2013-12-31 | $$54.69 M | -3916.71% |
| 2012-12-31 | $-$1.44 Million | -16.28% |
| 2011-12-31 | $-$1.72 Million | -277.5% |
| 2010-12-31 | $$0.96 M | -410.05% |
| 2009-12-31 | $-$0.32 Million | -1763.65% |
| 2008-12-31 | $$0.01 M | -95.52% |
| 2007-12-31 | $$0.41 M | -75.25% |
| 2006-12-31 | $$1.68 M | 28.38% |
| 2005-12-31 | $$1.31 M | 25% |
| 2004-12-31 | $$1.05 M | 21.4% |
| 2003-12-31 | $$0.86 M | 17.61% |
| 2002-12-31 | $$0.73 M | 9.57% |
| 2001-12-31 | $$0.67 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Agile Therapeutics
AGRX | -$21.92 Million | -181.94% | 🇺🇸 USA |
 Lannett Company LCI | -$0.42 Billion | -1,641.73% | 🇺🇸 USA |
 Pfizer PFE | $90.63 B | 338,856.62% | 🇺🇸 USA |
 AbbVie ABBV | $1.46 B | 5,367.46% | 🇺🇸 USA |
 Royalty Pharma RPRX | $9.78 B | 36,506.81% | 🇬🇧 UK |